|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
24
|
|
pubmed:dateCreated |
2009-12-16
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Cangrelor, a nonthienopyridine adenosine triphosphate analogue, is an intravenous blocker of the adenosine diphosphate receptor P2Y(12). This agent might have a role in the treatment of patients who require rapid, predictable, and profound but reversible platelet inhibition.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:AmineMagedM,
pubmed-author:AngiolilloDominick JDJ,
pubmed-author:BeckerRichard CRC,
pubmed-author:BhattDeepak LDL,
pubmed-author:ChewDerek PDP,
pubmed-author:FrenchWilliam JWJ,
pubmed-author:GibsonC MichaelCM,
pubmed-author:GoodmanShaun GSG,
pubmed-author:HarringtonRobert ARA,
pubmed-author:KleimanNeal SNS,
pubmed-author:LeischFranzF,
pubmed-author:LincoffA MichaelAM,
pubmed-author:MahaffeyKenneth WKW,
pubmed-author:McNultyStevenS,
pubmed-author:MontalescotGillesG,
pubmed-author:ParikhKeyur HKH,
pubmed-author:PollackCharles VCVJr,
pubmed-author:SkerjanecSimonaS,
pubmed-author:StoneGregg WGW,
pubmed-author:WhiteHarvey DHD
|
|
pubmed:copyrightInfo |
2009 Massachusetts Medical Society
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
10
|
|
pubmed:volume |
361
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2318-29
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19915221-Acute Coronary Syndrome,
pubmed-meshheading:19915221-Adenosine Monophosphate,
pubmed-meshheading:19915221-Administration, Oral,
pubmed-meshheading:19915221-Aged,
pubmed-meshheading:19915221-Angioplasty, Balloon, Coronary,
pubmed-meshheading:19915221-Combined Modality Therapy,
pubmed-meshheading:19915221-Double-Blind Method,
pubmed-meshheading:19915221-Female,
pubmed-meshheading:19915221-Hemorrhage,
pubmed-meshheading:19915221-Humans,
pubmed-meshheading:19915221-Infusions, Intravenous,
pubmed-meshheading:19915221-Male,
pubmed-meshheading:19915221-Middle Aged,
pubmed-meshheading:19915221-Myocardial Infarction,
pubmed-meshheading:19915221-Platelet Aggregation Inhibitors,
pubmed-meshheading:19915221-Retreatment,
pubmed-meshheading:19915221-Ticlopidine,
pubmed-meshheading:19915221-Treatment Failure
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Platelet inhibition with cangrelor in patients undergoing PCI.
|
|
pubmed:affiliation |
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA. robert.harrington@duke.edu
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
